Exports of Medicines Temporarily Suspended to Ensure National Supply
The National Medicines and Health Products Authority (Infarmed) has updated the list of medicines whose export is temporarily banned. The new version includes eight more drugs than the previous month’s and covers essential medicines used to treat heart failure, osteoporosis, psychiatric disorders (antipsychotics), pain (analgesics) and bacterial infections (antibiotics).
Anvisa promotes direct consultation on new regulatory framework for medical devices
The National Health Surveillance Agency (Anvisa) has announced the opening of a targeted consultation on the new proposal for a federal regulatory framework for medical devices. The initiative will be launched at a virtual event on May 13, at 9am (Brasília time), via the Microsoft Teams platform.
Public Consultation on Medicinal Cannabis Products: Anvisa’s Main Proposals
As of April 4, 2025, Anvisa launched a public consultation (CP 1.316/2025) to update the rules on cannabis products for medicinal use in Brazil.
Public Consultation on the Revision of RDC 327/2019: Main Changes and Criticisms
On March 26, 2025, the public consultation on the revision of RDC 327/2019, which regulates the health authorization, manufacture, import, marketing, prescription and inspection of cannabis-based products for medicinal purposes in Brazil, was approved.
FDA Proposes New Front-of-Package Nutrition Label to Help Consumers Make Healthier Choices
FDA proposes a new front-of-package nutrition label to help consumers make healthier food choices, focusing on key nutrients like saturated fat, sodium, and added sugars, promoting better public health.
APMC Conducts Innovative Study on Medicinal Cannabis for Osteoporosis and Chronic Pain in Women
The European Commission has launched a public consultation on medical device regulations. Participate by March 21, 2025, and contribute to their evaluation.